$1,052,936
＋2.3%
President and Chief Executive Officer
2024
$940k
45 hrs/wk
$114k
--
President and Chief Executive Officer at Global Alliance for Tb Drug Development Inc.
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Dr Melvin Spigelman has been listed as an employee of Global Alliance for Tb Drug Development Inc. in Form 990 filings since fiscal year 2017. Total compensation for Dr Melvin Spigelman has increased by 27.8% from 2017 to 2024.